Reset Pharma Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $11.1M

  • Investors
  • 9

Reset Pharma General Information

Description

Operator of a neuro-biotechnology therapies intended to improve mental health by resetting neural pathways associated with psychological trauma. The company offers psilocybin-inspired treatments and research-driven approaches, enabling patients with life-altering illnesses to address emotional distress and regain psychological well-being.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 98 Cuttermill Road
  • Suite 466
  • Great Neck, NY 11021
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 98 Cuttermill Road
  • Suite 466
  • Great Neck, NY 11021
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reset Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 16-Feb-2022 $11.1M Completed Product Development
To view Reset Pharma’s complete valuation and funding history, request access »

Reset Pharma Patents

Reset Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024263859-A1 Psilocin or psilocybin for use in the treatment of demoralisation syndrome Inactive 22-Jun-2023
GB-202207765-D0 Administration of a psychedelic compound Inactive 26-May-2022
GB-202207766-D0 Administration of a psychedelic compound Inactive 26-May-2022
GB-202207767-D0 Administration of a psychedelic compound Inactive 26-May-2022
US-20230364007-A1 Administration of a psychedelic compound Pending 13-May-2022 A61K9/0019
To view Reset Pharma’s complete patent history, request access »

Reset Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reset Pharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ayuh Ventures Venture Capital Minority
Gaingels Venture Capital Minority
Iter Investments Venture Capital Minority
Merida Capital Holdings Growth/Expansion Minority
MSA Capital (Family Office) Family Office Minority
You’re viewing 5 of 9 investors. Get the full list »

Reset Pharma FAQs

  • When was Reset Pharma founded?

    Reset Pharma was founded in 2020.

  • Where is Reset Pharma headquartered?

    Reset Pharma is headquartered in Great Neck, NY.

  • What is the size of Reset Pharma?

    Reset Pharma has 5 total employees.

  • What industry is Reset Pharma in?

    Reset Pharma’s primary industry is Drug Discovery.

  • Is Reset Pharma a private or public company?

    Reset Pharma is a Private company.

  • What is Reset Pharma’s current revenue?

    The current revenue for Reset Pharma is .

  • How much funding has Reset Pharma raised over time?

    Reset Pharma has raised $11.1M.

  • Who are Reset Pharma’s investors?

    Ayuh Ventures, Gaingels, Iter Investments, Merida Capital Holdings, and MSA Capital (Family Office) are 5 of 9 investors who have invested in Reset Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process